From Life Sciences to Aesthetics

A natural solution for facial aging

We are developing an innovative technology for doctors to remodel facial & body fat tissues.

Contact us
Learn More

Clinical Pipeline

We aim to be a leading Life Sciences company innovating Medical Aesthetics with superior solutions.

We are developing and clinically testing injections for mid-facial volume loss and buttock enhancement.

Fat cell/tissue volume is increased with plant-derived lipids. Patient's tissues provide superior & longer-term natural results.

PB&B products are currently limited to investigational use only.

12 patents

granted in top market countries and 20 others pending

$2.9 billion

in global filler sales in 2019; $4.2 billion projected by 2023

10x

in global aesthetics product sales over 2010-2020

+15 million

facial filler procedures in 2019; 21 million projected by 2023

Science

A new generation of fillers and soft tissue remodeling injections

PB&B is the first natural filler to re-volumize fat with lipids. The patient’s own fat tissues provide the result by covering wrinkles and signs of aging. Over 30 years in medical and scientific research were used to create PB&B’s unique technology.

As the face ages, fat volume is lost causing facial sagging and wrinkles. Molecular biology pathways are used to enhance fat cell volume for natural long-term results.

Natural

All injected componentes are naturally present in human body.

Minimally invasive

A superior and safer alternative to fillers for plastic surgeons and dermatologists.

MILESTONES

We have been growing in the last 7 years,
achieving awards in Switzerland and the world

ISO-13485 CertificationISO-13485 Certification
2020

ISO-13485 Certification

ISO-13485 Certification

Quality management system certified by TÜV-SÜD
Hangzhou Innovation GrantHangzhou Innovation Grant
2020

Hangzhou Innovation Grant

Hangzhou Innovation Grant

¥3 million CNY grant to kick-start clinical operations in China
Venture Leaders ChinaVenture Leaders China
2020

Venture Leaders China

Venture Leaders China

Swiss national startup team 2020 selection
IMCASIMCAS
2018

IMCAS

IMCAS

Innovation of the Year 2018 at the largest global medical aesthetics congress
StartXStartX
2018

StartX

StartX

Stanford's startup accelerator in Silicon Valley
Horizon 2020Horizon 2020
2017

Horizon 2020

Horizon 2020

Innovation grant from the European Comission
$3M Series A$3M Series A
2016

$3M Series A

$3M Series A

Funding closed with a private investor
Venture Leaders USAVenture Leaders USA
2016

Venture Leaders USA

Venture Leaders USA

Swiss national startup team 2016 selection
MassChallenge BostonMassChallenge Boston
2015

MassChallenge Boston

MassChallenge Boston

Finalist at the largest global startup accelerator
IMD Startup CompetitionIMD Startup Competition
2015

IMD Startup Competition

IMD Startup Competition

Finalist at the #1 executive education business school globally
CTI grantCTI grant
2014

CTI grant

CTI grant

$210k innovation grant from the Swiss Federal government
HUG Innovation TrophyHUG Innovation Trophy
2014

HUG Innovation Trophy

HUG Innovation Trophy

Awarded by the University Hospitals of Geneva (HUG)
Proof of ConceptProof of Concept
2014

Proof of Concept

Proof of Concept

Demonstrated in collaboration with HUG and EPFL
EPFL-HUG R&D projectEPFL-HUG R&D project
2014

EPFL-HUG R&D project

EPFL-HUG R&D project

Partnership with EPFL and HUG to develop and test the technology
Vaud CantonVaud Canton
2014

Vaud Canton

Vaud Canton

$100k in financial support from the state’s economic promotion office
PB&B Ltd. founded on Dec 20, 2013PB&B Ltd. founded on Dec 20, 2013
2013

PB&B Ltd. founded on Dec 20, 2013

PB&B Ltd. founded on Dec 20, 2013

Venture KickVenture Kick
2013

Venture Kick

Venture Kick

$130k won from philanthropic Swiss startup support organization
Previous
More

Team & Board

An international team of Bioengineers & Doctors have come together to develop this disruptive technology & products

Management Team

Anthony Aho

Chief Executive Officer & President
View moreManagement Team
Management Team

Elena Musa, PhD

Clinical Director
View moreManagement Team
Advisory board

Dr. Grant Stevens, MD

Medical Advisory Board Member
Los Angeles, USA
View moreAdvisory board
Advisory board

Dr. William Gerald (Jay) Austen, MD

Medical Advisory Board Member
Boston, USA
View moreAdvisory board
Advisory board

Dr. Pierre Quinodoz, MD

Medical Advisory Board Member
Geneva, Switzerland
View moreAdvisory board
Advisory board

Aubrey Rankin

Business Advisory Board Member
San Francisco, USA
View moreAdvisory board

Do you want to know more?

Contact Investor Relations

Learn more about our road ahead.

We use cookies to provide a better browsing experience.
AcceptRead more